26
NPS Score
VS
Johnson & Johnson Claimed Company
- EMPLOYEE
PARTICIPANTS - 1044
- TOTAL
RATINGS
Novartis Oncology
- EMPLOYEE
PARTICIPANTS - 14
- TOTAL
RATINGS
Johnson & Johnson vs Novartis Oncology
Compare Johnson & Johnson versus Novartis Oncology for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 1044 employees and customers of Johnson & Johnson and 14 employees and customers of Novartis Oncology.
Johnson & Johnson
Johnson & Johnson's brand is ranked #89 in the list of Global Top 100 Brands, as rated by customers of Johnson & Johnson. Their current market cap is $428.68B.
Novartis Oncology
Novartis Oncology's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Novartis Oncology.
4/5
Product Quality
4.1/5
3.9/5
Pricing
3.7/5
4/5
Customer Service
4/5
| 52% | Promoters |
|---|---|
| 22% | Passive |
| 26% | Detractors |
Net Promoter Score
Winner by 17
9
NPS Score
| 42% | Promoters |
|---|---|
| 25% | Passive |
| 33% | Detractors |
See how Johnson & Johnson compares to its competitors
See how Novartis Oncology compares to its competitors
Working at Johnson & Johnson vs Working at Novartis Oncology
76 / 100
CEO Rating
Winner by 8%
68 / 100
CEO Rating
Johnson & Johnson
Johnson & Johnson doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Novartis Oncology
Employees at Novartis Oncology rate their CEO, Liz Barrett, 68/100. This score is 8% lower than the scores of Johnson & Johnson's CEO, Joaquin Duato.